Related Experiment Video
Updated: Jun 26, 2025

05:47
Animal Models of Depression - Chronic Despair Model CDM
Published on: September 23, 2021
7.2K
Optogenetic behavioral studies in depression research: A systematic review.
Anika Spreen1,2, Dana Alkhoury1, Henrik Walter1
1Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Psychiatry and Neurosciences, CCM, Berlin, Germany.
Iscience
|May 10, 2024
Summary
Optogenetics significantly impacts depression research by altering mouse and rat behaviors like social interaction and mobility. This review synthesizes 248 tests from 168 studies, analyzing optogenetic stimulation
Area of Science:
- Neuroscience
- Behavioral Science
- Genetics
Background:
- Optogenetics offers powerful tools for dissecting neural circuits implicated in depression.
- Understanding the behavioral effects of optogenetic manipulation is crucial for translational research.
Purpose of the Study:
- To quantitatively analyze the impact of optogenetic stimulation on depression-related behaviors in rodents.
- To synthesize outcomes from optogenetic studies on social interaction, sucrose consumption, and mobility.
Main Methods:
- Systematic review and quantitative analysis of 37 articles.
- Inclusion of 168 studies and 248 behavioral tests in mice and rats.
- Evaluation of behavioral changes (positive, negative, not effective) based on stimulation parameters and animal models.
Main Results:
- Behavioral alterations were observed following optogenetic stimulation.
- Outcomes varied depending on the specific behavior, animal cohort, stimulation type, and targeted neural circuits/cell types.
- Analysis included both positive and null results, providing a balanced perspective.
Conclusions:
- Optogenetic stimulation demonstrably influences rodent behaviors relevant to depression.
- This synthesis provides a comprehensive overview of optogenetic behavioral research in depression models.
- Further research can refine optogenetic strategies for understanding and potentially treating depression.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
226
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
226
Depression: Overview
241
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
241

